Possible Factors Involved in Oral Inactivity of Meropenem, a Carbapenem Antibiotic

Pharmacology & Pharmacy

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.net/journal/pp
E-mail: [email protected]

Citations

"Possible Factors Involved in Oral Inactivity of Meropenem, a Carbapenem Antibiotic"
written by Toshihide Saito, Rinako Sawazaki, Kaori Ujiie, Masako Oda, Hiroshi Saitoh,
published by Pharmacology & Pharmacy, Vol.3 No.2, 2012

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Preferential meropenem absorption activated by 1α, 25-dihydroxyvitamin D3 and shared with foscarnet, a phosphate transporter substrate, in the rat ileum
	Drug Metabolism and …, 2024

[2]	Pharmacokinetic changes of meropenem in sepsis patients: A Comparative Review
	2022

[3]	PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery
	2021

[4]	Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem
	2021

[5]	Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants
	2021

[6]	Carbapenems: A Short Review about their Current Status
	International Journal of Current Science Research and Review, 2021

[7]	Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery
	2021

[8]	The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients
	2020

[9]	Oral meropenem for superbugs: challenges and opportunities
	2020

[10]	Intermittent versus daily dosing of meropenem in haemodialysis patients–A retrospective observational exploratory study
	2020

[11]	Solid nanoparticles for oral antimicrobial drug delivery: a review
	2019

[12]	CHARACTERIZATION OF PEPTIDES AND PROTEINS FROM EPIDERMAL MUCUS OF CLIMBING PERCH Anabas testudineus (Bloch, 1972) WITH …
	2018

[13]	Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism
	PloS one, 2015

[14]	Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
	Journal of research in pharmacy practice, 2015

[15]	Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis
	Bioorganic & Medicinal Chemistry, 2013

[16]	Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis.
	NULL 2013

[17]	亚胺培南/西司他丁与美罗培南对下呼吸道感染患者的临床用药研究
	中外医疗, 2013

[18]	Pre-clinical Drug Development of 9-aminoacridines for Malignant Glioma and Meropenem Prodrugs for Drug-Resistant Tuberculosis
	NULL 2012

[1]	Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem AAPS PharmSciTech, 2025 DOI:10.1208/s12249-024-03026-y

[2]	Nanomedicine approaches to enhance the effectiveness of meropenem: a strategy to tackle antimicrobial resistance Discover Nano, 2025 DOI:10.1186/s11671-025-04244-4

[3]	Preferential meropenem absorption activated by 1α,25-dihydroxyvitamin D3 and shared with foscarnet, a phosphate transporter substrate, in the rat ileum Drug Metabolism and Pharmacokinetics, 2024 DOI:10.1016/j.dmpk.2024.100997

[4]	Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem ACS Biomaterials Science & Engineering, 2021 DOI:10.1021/acsbiomaterials.0c01284

[5]	Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery Acta Biomaterialia, 2021 DOI:10.1016/j.actbio.2021.03.042

[6]	Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants Clinical Pharmacokinetics, 2021 DOI:10.1007/s40262-021-01046-6

[7]	PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery International Journal of Pharmaceutics, 2021 DOI:10.1016/j.ijpharm.2021.120280

[8]	The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients Antibiotics, 2020 DOI:10.3390/antibiotics9110815

[9]	Oral meropenem for superbugs: challenges and opportunities Drug Discovery Today, 2020 DOI:10.1016/j.drudis.2020.11.004

[10]	Solid nanoparticles for oral antimicrobial drug delivery: a review Drug Discovery Today, 2019 DOI:10.1016/j.drudis.2019.01.004

[11]	Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism PLOS ONE, 2015 DOI:10.1371/journal.pone.0142352

[12]	Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis Bioorganic & Medicinal Chemistry, 2013 DOI:10.1016/j.bmc.2013.05.024

	[email protected]
	+86 18163351462 (WhatsApp)
	1655362766
	SCIRP WeChat

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Pharmacology & Pharmacy

Pharmacology & Pharmacy

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies